JDDW2020 Close
Keyword Search
Adding space between the words will produce results as inserting the word "AND".
Strategic International Session1(W)(JGES・JSGE・JSGCS)
Thu. October 31st   14:30 - 17:00   Room 9: Portopia Hotel Main Building Kairaku 3
ST1-2_E
Advancing Endoscopic Anti-reflux Therapy: Anti-reflux Mucoplasty for PPI Refractory/Dependent Gastro-esophageal Reflux Disease
Kazuki Yamamoto1, Yuto Shimamura1, Haruhiro Inoue1
1Digestive Diseases Center, Showa University Koto Toyosu Hospital
Background:
Anti-reflux mucosectomy (ARMS) and anti-reflux mucosal ablation (ARMA) aimed at managing PPI/PCAB refractory/dependent GERD. Despite their documented effectiveness, relying solely on natural healing for ulcer scar contraction carries risks of stricture and bleeding. To address this concern, we introduced anti-reflux mucoplasty (ARM-P), which involves the immediate closure of mucosal defects following mucosectomy. This study aims to evaluate the safety, feasibility, and efficacy of ARM-P.
Methods:
A retrospective single-center study analyzed prospectively collected data from October 2022 to January 2024. The study evaluated various aspects including ARM-P's technical success, pre- and post-procedure GERD-Health Related Quality of Life Questionnaire (GERD-HRQL), GerdQ, and Frequency Scale for the Symptoms of GERD (FSSG) scores, alongside the rate of discontinuation of PPI medication.
Results:
Thirty-nine patients (mean age: 51.9 years, SD±17.1) underwent ARM-P, achieving 100% technical success in a median procedure duration of 68 minutes (IQR: 25-45). Following ARM-P, 51.3% (20/39) ceased PPI medication, while 17.9% (7/39) halved their PPI dose. Median GERD-HRQL score improved significantly from 24.5 (IQR: 0-46) to 9.5 (IQR: 0-39) (P <0.001), GERDQ score decreased from 8 (IQR: 2-15) to 7 (IQR: 1-13) (P = 0.0027), and FSSG score reduced from 27.5 (IQR: 2-46) to 11 (IQR: 0-40) (P <0.001). No postoperative bleeding or stenosis occurred.
Conclusions:
This study highlights the procedural safety, technical feasibility, and short-term efficacy of ARM-P.
Index Term 1: GERD
Index Term 2: endoscopic anti-reflux therapies
Page Top